NO20025873L - Meget effektiv levering av en stor terapeutisk mengde aerosol - Google Patents
Meget effektiv levering av en stor terapeutisk mengde aerosolInfo
- Publication number
- NO20025873L NO20025873L NO20025873A NO20025873A NO20025873L NO 20025873 L NO20025873 L NO 20025873L NO 20025873 A NO20025873 A NO 20025873A NO 20025873 A NO20025873 A NO 20025873A NO 20025873 L NO20025873 L NO 20025873L
- Authority
- NO
- Norway
- Prior art keywords
- particles
- agent
- aerosol
- therapeutic amount
- effective delivery
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 9
- 239000000203 mixture Substances 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/591,307 US6858199B1 (en) | 2000-06-09 | 2000-06-09 | High efficient delivery of a large therapeutic mass aerosol |
PCT/US2001/018491 WO2001095874A2 (en) | 2000-06-09 | 2001-06-08 | Highly efficient delivery of a large therapeutic mass aerosol |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025873D0 NO20025873D0 (no) | 2002-12-06 |
NO20025873L true NO20025873L (no) | 2003-02-06 |
Family
ID=24365965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025873A NO20025873L (no) | 2000-06-09 | 2002-12-06 | Meget effektiv levering av en stor terapeutisk mengde aerosol |
Country Status (21)
Country | Link |
---|---|
US (6) | US6858199B1 (no) |
EP (2) | EP1767196A3 (no) |
JP (2) | JP2004503482A (no) |
KR (1) | KR100697479B1 (no) |
CN (1) | CN100589796C (no) |
AT (1) | ATE357222T1 (no) |
AU (2) | AU2001275368B2 (no) |
CA (1) | CA2412561C (no) |
DE (1) | DE60127407T2 (no) |
DK (1) | DK1296663T3 (no) |
ES (1) | ES2283417T3 (no) |
HK (1) | HK1051139A1 (no) |
IL (1) | IL153281A0 (no) |
MX (1) | MXPA02012023A (no) |
NO (1) | NO20025873L (no) |
NZ (1) | NZ523254A (no) |
PL (1) | PL360287A1 (no) |
PT (1) | PT1296663E (no) |
RU (1) | RU2275900C2 (no) |
SI (1) | SI1296663T1 (no) |
WO (1) | WO2001095874A2 (no) |
Families Citing this family (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US6749835B1 (en) * | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6613308B2 (en) * | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US20020150626A1 (en) * | 2000-10-16 | 2002-10-17 | Kohane Daniel S. | Lipid-protein-sugar particles for delivery of nucleic acids |
CA2468958C (en) | 2001-12-19 | 2012-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
JP2005526769A (ja) * | 2002-03-15 | 2005-09-08 | ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド | 治療剤を全身搬送するための中央気道投与 |
US7008644B2 (en) * | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
JP2005520843A (ja) | 2002-03-20 | 2005-07-14 | アドバンスト インハレーション リサーチ,インコーポレイテッド | 呼吸用持続性治療製剤 |
ES2300568T3 (es) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
US7879358B2 (en) | 2002-03-20 | 2011-02-01 | Alkermes, Inc. | Pulmonary delivery for levodopa |
US6930137B2 (en) * | 2002-05-31 | 2005-08-16 | Fina Technology, Inc. | Method of improving blown film processing performance and physical properties |
EP3308772B8 (en) * | 2002-06-28 | 2021-03-17 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
AU2003232081B2 (en) * | 2002-07-03 | 2009-02-05 | Brandeis University | Central airway administration for systemic delivery of therapeutics |
US6966990B2 (en) * | 2002-10-11 | 2005-11-22 | Ferro Corporation | Composite particles and method for preparing |
CA2522231A1 (en) * | 2003-04-14 | 2004-10-21 | Vectura Ltd | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
DE10317461A1 (de) * | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung |
GB0313604D0 (en) * | 2003-06-12 | 2003-07-16 | Britannia Pharmaceuticals Ltd | Delivery device for powdered medicament |
AU2004249166B2 (en) * | 2003-06-13 | 2008-10-09 | Alkermes, Inc. | Low dose pharmaceutical powders for inhalation |
AU2004272077A1 (en) * | 2003-09-10 | 2005-03-24 | Map Pharmaceuticals, Inc. | Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation |
GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
WO2005077338A1 (en) * | 2004-02-10 | 2005-08-25 | Advanced Inhalation Research, Inc. | Particles for inhalation rapid release properties |
JP2007534693A (ja) * | 2004-04-23 | 2007-11-29 | サイデックス・インコーポレイテッド | スルホアルキルエーテルシクロデキストリンを含有するdpi製剤 |
CA2575692C (en) | 2004-08-20 | 2014-10-14 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
BR122019022692B1 (pt) | 2004-08-23 | 2023-01-10 | Mannkind Corporation | Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo |
SE0402345L (sv) * | 2004-09-24 | 2006-03-25 | Mederio Ag | Uppmätt läkemedelsdos |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
US20060134009A1 (en) * | 2004-12-16 | 2006-06-22 | Daniel Deaver | Low dose corticosteroid powders for inhalation |
EA016072B1 (ru) * | 2005-05-18 | 2012-01-30 | Палметрикс Инк. | Применение состава соли кальция для изменения биофизических свойств слизистой оболочки |
MX2008002023A (es) * | 2005-08-11 | 2008-04-08 | Harvard College | Metodos y composiciones para secar formas celulares. |
HUE028691T2 (en) | 2005-09-14 | 2016-12-28 | Mannkind Corp | A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
US20070123449A1 (en) * | 2005-11-01 | 2007-05-31 | Advanced Inhalation Research, Inc. | High load particles for inhalation having rapid release properties |
EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
GB0616299D0 (en) * | 2006-08-16 | 2006-09-27 | Cambridge Consultants | Drug Capsules for dry power inhalers |
EP2086617A4 (en) | 2006-10-26 | 2013-11-20 | Next Breath Llc | INHALATION SYSTEM BASED ON PHOSPHOLIPIDS |
US7745566B2 (en) * | 2007-01-23 | 2010-06-29 | Ferro Corporation | Methods for the purification of polymers |
US20080260852A1 (en) * | 2007-01-23 | 2008-10-23 | Ferro Pfanstiehl Laboratories, Inc. | Supercritical fluid extraction produced by in-line homogenization |
CA2677838C (en) * | 2007-02-11 | 2017-08-01 | Map Pharmaceuticals, Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
EP2152316A4 (en) * | 2007-04-26 | 2011-03-23 | Quark Pharmaceuticals Inc | THERAPEUTIC DELIVERY OF INHIBITORY NUCLEIC ACID MOLECULES IN THE RESPIRATORY SYSTEM |
WO2009052869A1 (en) * | 2007-10-26 | 2009-04-30 | Universita' Degli Studi Di Parma | Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation |
GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
EP2220115A2 (en) * | 2007-12-13 | 2010-08-25 | Glaxo Group Limited | Polypeptides, antibody variable domains & antagonists |
CA2710274A1 (en) * | 2007-12-20 | 2009-07-02 | Astrazeneca Ab | Device and method for deaggregating powder 854 |
AR072114A1 (es) | 2008-06-13 | 2010-08-04 | Mannkind Corp | Un inhalador de polvo seco y sistema para suministro de farmacos |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
BRPI0914308B8 (pt) * | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
US20110189299A1 (en) * | 2008-07-01 | 2011-08-04 | Nitto Denko Corporation | Pharmaceutical composition containing surface-coated microparticles |
US20110253140A1 (en) * | 2008-07-30 | 2011-10-20 | Stc.Unm | Formulations containing large-size carrier particles for dry powder inhalation aerosols |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9717867B2 (en) | 2009-02-27 | 2017-08-01 | Pari GmbH Spezialisten für effektive Inhalation | Method for operating an aerosol inhalation device and aerosol inhalation device |
CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
EP3184099A1 (en) | 2009-03-26 | 2017-06-28 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
US20110171141A1 (en) * | 2009-06-26 | 2011-07-14 | Kellerman Donald J | Administration of dihydroergotamine mesylate particles using a metered dose inhaler |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
EP2380618A1 (en) * | 2010-04-26 | 2011-10-26 | PARI Pharma GmbH | Operating method for an aerosol delivery device and aerosol delivery device |
RU2571331C1 (ru) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
WO2012030647A1 (en) | 2010-08-30 | 2012-03-08 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
US9061352B2 (en) | 2010-08-30 | 2015-06-23 | Pulmatrix, Inc. | Dry powder formulations and methods for treating pulmonary diseases |
WO2012044736A1 (en) * | 2010-09-29 | 2012-04-05 | Pulmatrix, Inc. | Monovalent metal cation dry powders for inhalation |
WO2012050945A1 (en) | 2010-09-29 | 2012-04-19 | Pulmatrix, Inc. | Cationic dry powders |
JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
JP6018640B2 (ja) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム |
PT106094A (pt) | 2012-01-13 | 2013-07-15 | Hovione Farmaciencia S A | Administração por inalação de formulações com dose elevada |
NZ629722A (en) | 2012-02-29 | 2017-03-31 | Pulmatrix Operating Co Inc | Inhalable dry powders |
RU2495682C1 (ru) * | 2012-07-12 | 2013-10-20 | Дарья Сергеевна Петренко | Способ доставки лекарственного средства при лечении или профилактике табакокурения и/или заболеваний органов дыхания |
SG11201500218VA (en) | 2012-07-12 | 2015-03-30 | Mannkind Corp | Dry powder drug delivery systems and methods |
EP2705838A1 (en) * | 2012-09-06 | 2014-03-12 | Xspray Microparticles Ab | Tiotropium preparations |
KR20210075224A (ko) | 2012-10-22 | 2021-06-22 | 키비타스 테라퓨틱스, 인코포레이티드. | 파킨슨병의 빠른 경감을 위한 레보도파 제형 |
NZ708415A (en) | 2012-10-22 | 2018-11-30 | Civitas Therapeutics Inc | Reducing inter-patient variability of levodopa plasma concentrations |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US11052202B2 (en) * | 2012-11-07 | 2021-07-06 | Chiesi Farmaceutici S.P.A. | Drug delivery device for the treatment of patients with respiratory diseases |
BR112015010601B1 (pt) | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | Composição farmacêutica e uso da composição |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
CN105209013B (zh) * | 2013-03-14 | 2019-04-26 | 诺华股份有限公司 | 喷雾干燥制剂经喷雾混合的脱非晶化 |
WO2014144895A1 (en) | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
JP6473738B2 (ja) | 2013-04-01 | 2019-02-20 | パルマトリックス,インコーポレイテッド | チオトロピウム乾燥粉末 |
EP2991634A1 (en) | 2013-04-30 | 2016-03-09 | Otitopic Inc. | Dry powder formulations and methods of use |
AU2014290438B2 (en) | 2013-07-18 | 2019-11-07 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
DK3107548T3 (da) | 2014-02-20 | 2022-07-18 | Otitopic Inc | Tørpulverformuleringer til inhalation |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
CN106659685B (zh) | 2014-04-21 | 2021-02-05 | 丝维塔斯治疗公司 | 快速减轻帕金森病中的运动波动 |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
MA40910A (fr) | 2014-11-07 | 2017-09-12 | Civitas Therapeutics Inc | Poudres de rapamycine pour administration pulmonaire |
JP6921759B2 (ja) | 2015-06-04 | 2021-08-18 | クリティテック・インコーポレイテッド | 捕集装置および使用法 |
KR20180052566A (ko) | 2015-07-02 | 2018-05-18 | 키비타스 테라퓨틱스, 인코포레이티드. | 폐 전달용 트립탄 분말 |
RU2731212C2 (ru) * | 2015-09-09 | 2020-08-31 | Новартис Аг | Направленная доставка высушенных распылением композиций в легкие |
AU2017246316B2 (en) | 2016-04-04 | 2022-09-29 | Crititech, Inc. | Methods for solid tumor treatment |
US10898494B2 (en) | 2016-05-05 | 2021-01-26 | Liquidia Technologies, Inc. | Dry powder treprostinil for the treatment of pulmonary hypertension |
WO2018163085A1 (en) * | 2017-03-07 | 2018-09-13 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
SG11201909840TA (en) | 2017-06-09 | 2019-11-28 | Crititech Inc | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
CA3063436A1 (en) | 2017-06-14 | 2018-12-20 | Crititech, Inc. | Methods for treating lung disorders |
CA3076919A1 (en) | 2017-10-03 | 2019-04-11 | Crititech, Inc. | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
CN117928673A (zh) * | 2019-03-08 | 2024-04-26 | 克罗玛夫洛技术公司 | 固体着色剂分配装置和包括该装置的着色机 |
CN113318097A (zh) * | 2021-04-29 | 2021-08-31 | 珠海瑞思普利医药科技有限公司 | 一种抗特发性肺纤维化的粉雾剂及制备方法 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
US5260306A (en) | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
EP0072046B1 (en) * | 1981-07-24 | 1986-01-15 | FISONS plc | Inhalation drugs, methods for their production and pharmaceutical formulations containing them |
IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
US5174988A (en) | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
US5304125A (en) | 1990-10-05 | 1994-04-19 | The University Of North Carolina | Apparatus for administering solid particulate aerosols to the lungs |
US5993805A (en) | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5830853A (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
GB9313650D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
KR100419037B1 (ko) * | 1994-03-07 | 2004-06-12 | 넥타르 테라퓨틱스 | 폐를통한인슐린의전달방법및그조성물 |
GB9413202D0 (en) | 1994-06-30 | 1994-08-24 | Univ Bradford | Method and apparatus for the formation of particles |
US5641510A (en) | 1994-07-01 | 1997-06-24 | Genentech, Inc. | Method for treating capsules used for drug storage |
KR970705979A (ko) | 1994-09-29 | 1997-11-03 | 디 히스 | 치료용 매개체로서의 분무-건조 미소입자 (Spray-dried microparticles as therapeutic vehicles) |
US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
CA2218074C (en) | 1995-04-14 | 2002-10-08 | Mohammed Eljamal | Powdered pharmaceutical formulations having improved dispersibility |
US6165463A (en) | 1997-10-16 | 2000-12-26 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6652837B1 (en) | 1996-05-24 | 2003-11-25 | Massachusetts Institute Of Technology | Preparation of novel particles for inhalation |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
GB9621825D0 (en) | 1996-10-19 | 1996-12-11 | Andaris Ltd | Microparticles and their use as therapeutic vehicles |
CA2277801C (en) | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
EP1019020A1 (en) | 1997-09-29 | 2000-07-19 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
US20010053761A1 (en) * | 1998-01-08 | 2001-12-20 | Dimarchi Richard Dennis | Method for administering aspb28-human insulin |
US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
WO1999066903A2 (en) | 1998-06-24 | 1999-12-29 | Advanced Inhalation Research, Inc. | Large porous particles emitted from an inhaler |
CA2341624C (en) | 1998-08-25 | 2008-12-02 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
GB9827145D0 (en) * | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
US6586008B1 (en) | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
WO2001032144A1 (en) * | 1999-10-29 | 2001-05-10 | Inhale Therapeutic Systems, Inc. | Dry powder compositions having improved dispersivity |
WO2001051030A1 (en) | 2000-01-10 | 2001-07-19 | Dura Pharmaceuticals, Inc. | Pharmaceutical formulation and method for pulmonary and oral delivery |
US6848197B2 (en) * | 2001-04-18 | 2005-02-01 | Advanced Inhalation Research, Inc. | Control of process humidity to produce large, porous particles |
-
2000
- 2000-06-09 US US09/591,307 patent/US6858199B1/en not_active Expired - Lifetime
-
2001
- 2001-06-08 ES ES01942072T patent/ES2283417T3/es not_active Expired - Lifetime
- 2001-06-08 RU RU2002134467/15A patent/RU2275900C2/ru not_active IP Right Cessation
- 2001-06-08 PT PT01942072T patent/PT1296663E/pt unknown
- 2001-06-08 SI SI200130734T patent/SI1296663T1/sl unknown
- 2001-06-08 NZ NZ523254A patent/NZ523254A/en unknown
- 2001-06-08 IL IL15328101A patent/IL153281A0/xx unknown
- 2001-06-08 US US09/878,146 patent/US7556798B2/en active Active
- 2001-06-08 AU AU2001275368A patent/AU2001275368B2/en not_active Ceased
- 2001-06-08 MX MXPA02012023A patent/MXPA02012023A/es active IP Right Grant
- 2001-06-08 DE DE60127407T patent/DE60127407T2/de not_active Revoked
- 2001-06-08 KR KR1020027016748A patent/KR100697479B1/ko not_active IP Right Cessation
- 2001-06-08 AT AT01942072T patent/ATE357222T1/de not_active IP Right Cessation
- 2001-06-08 DK DK01942072T patent/DK1296663T3/da active
- 2001-06-08 CN CN01812533A patent/CN100589796C/zh not_active Expired - Fee Related
- 2001-06-08 PL PL36028701A patent/PL360287A1/xx not_active Application Discontinuation
- 2001-06-08 EP EP07000049A patent/EP1767196A3/en not_active Withdrawn
- 2001-06-08 EP EP01942072A patent/EP1296663B1/en not_active Revoked
- 2001-06-08 AU AU7536801A patent/AU7536801A/xx active Pending
- 2001-06-08 CA CA002412561A patent/CA2412561C/en not_active Expired - Fee Related
- 2001-06-08 JP JP2002510053A patent/JP2004503482A/ja active Pending
- 2001-06-08 WO PCT/US2001/018491 patent/WO2001095874A2/en active IP Right Grant
-
2002
- 2002-12-06 NO NO20025873A patent/NO20025873L/no not_active Application Discontinuation
-
2003
- 2003-05-12 HK HK03103294A patent/HK1051139A1/xx not_active IP Right Cessation
- 2003-10-08 US US10/681,416 patent/US6921528B2/en not_active Expired - Lifetime
-
2008
- 2008-08-29 JP JP2008222436A patent/JP2009019047A/ja active Pending
- 2008-10-17 US US12/253,449 patent/US20090068274A1/en not_active Abandoned
-
2011
- 2011-12-22 US US13/334,236 patent/US8628754B2/en not_active Expired - Fee Related
-
2013
- 2013-12-10 US US14/101,500 patent/US20140178476A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20025873D0 (no) | Meget effektiv levering av en stor terapeutisk mengde aerosol | |
DK1719505T3 (da) | Farmaceutiske formuleringer til tørpulverinhalator i form af hårde pellets | |
EA200100338A1 (ru) | Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента | |
IS4179A (is) | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband | |
JO2430B1 (en) | Pharmaceutical formulas for dry powder inhalations in the form of solid pellets | |
DE60216588D1 (de) | Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen | |
TH59260B (th) | การให้สารออกฤทธิ์ที่ได้รับการทำเป็นแอโรซอล | |
TH59260A3 (th) | การให้สารออกฤทธิ์ที่ได้รับการทำเป็นแอโรซอล |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |